Assessing Fitting Guides in Alcon Multifocal Contact Lenses
NCT ID: NCT03118934
Last Updated: 2018-09-26
Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
188 participants
INTERVENTIONAL
2017-05-17
2017-07-28
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Clinical Comparison of Toric Contact Lenses Fit Characteristics
NCT05805345
Multifocal Lens Design Evaluation
NCT01997216
Evaluation of Delefilcon A Contact Lenses
NCT06884202
Multi-Center Clinical Evaluation of Two Daily Disposable Contact Lenses (Study 2)
NCT01917162
Multi-Center Clinical Evaluation of Two Daily Disposable Contact Lenses
NCT01898260
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
OTHER
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
AOA MF
Lotrafilcon B multifocal contact lenses worn bilaterally (in both eyes) for 10 ± 3 days
Lotrafilcon B multifocal contact lenses
Contact lenses for near, intermediate, and distance correction worn on a daily wear basis and cared for with participant's habitual lens care solution
DACP MF
Nelfilcon A multifocal contact lenses worn bilaterally for 10 ± 3 days
Nelfilcon A multifocal contact lenses
Contact lenses for near, intermediate, and distance correction worn on a daily disposable basis (removed every night and discarded) with a new pair of study lenses every morning
DT1 MF
Delefilcon A multifocal contact lenses worn bilaterally for 10 ± 3 days
Delefilcon A multifocal contact lenses
Contact lenses for near, intermediate, and distance correction worn on a daily disposable basis (removed every night and discarded) with a new pair of study lenses every morning
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Lotrafilcon B multifocal contact lenses
Contact lenses for near, intermediate, and distance correction worn on a daily wear basis and cared for with participant's habitual lens care solution
Nelfilcon A multifocal contact lenses
Contact lenses for near, intermediate, and distance correction worn on a daily disposable basis (removed every night and discarded) with a new pair of study lenses every morning
Delefilcon A multifocal contact lenses
Contact lenses for near, intermediate, and distance correction worn on a daily disposable basis (removed every night and discarded) with a new pair of study lenses every morning
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Normal eyes;
* Current full-time soft contact lens wearer needing presbyopia correction;
* Willing to wear lenses for a minimum of five days per week, six hours per day, and attend all study visits;
Exclusion Criteria
* Eye conditions (past or present) as specified in the protocol;
* Currently wearing Alcon multifocal (MF) contact lenses;
* Only one eye with functional vision;
* Contact lens wear in one eye only;
* Use of mechanical eyelid therapy or eyelid scrubs within 14 days before Visit 1 and not willing to discontinue during the study;
40 Years
65 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Alcon Research
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Clinical Trial Manager, Vision Care
Role: STUDY_DIRECTOR
Alcon Research
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Alcon Investigative Site
Phoenix, Arizona, United States
Alcon Investigative Site
San Diego, California, United States
Alcon Investigative Site
Pensacola, Florida, United States
Alcon Investigative Site
Tallahassee, Florida, United States
Alcon Investigative Site
Pittsburg, Kansas, United States
Alcon Investigative Site
Shawnee Mission, Kansas, United States
Alcon Investigative Site
Ann Arbor, Michigan, United States
Alcon Investigative Site
Eden Prairie, Minnesota, United States
Alcon Investigative Site
Medina, Minnesota, United States
Alcon Investigative Site
Raytown, Missouri, United States
Alcon Investigative Site
Powell, Ohio, United States
Alcon Investigative Site
Warwick, Rhode Island, United States
Alcon Investigative Site
Memphis, Tennessee, United States
Alcon Investigative Site
Memphis, Tennessee, United States
Alcon Investigative Site
Burnaby, British Columbia, Canada
Alcon Investigative Site
Toronto, Ontario, Canada
Alcon Investigative Site
Toronto, , Canada
Alcon Investigative Site
Coventry, , United Kingdom
Alcon Investigative Site
Hereford, , United Kingdom
Alcon Investigative Site
Monmouth, , United Kingdom
Countries
Review the countries where the study has at least one active or historical site.
Provided Documents
Download supplemental materials such as informed consent forms, study protocols, or participant manuals.
Document Type: Statistical Analysis Plan
Document Type: Study Protocol
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
CLK027-P001
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.